Variant report
Variant | esv3399291 |
---|---|
Chromosome Location | chr13:37880447-37880685 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191210318 | chr13:37880463-37880464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201277228 | chr13:37880482-37880483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375911819 | chr13:37880483-37880484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183064253 | chr13:37880484-37880485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs61283199 | chr13:37880497-37880498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58706493 | chr13:37880501-37880502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs56763309 | chr13:37880506-37880507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs199505970 | chr13:37880509-37880510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536570513 | chr13:37880511-37880512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370296388 | chr13:37880513-37880514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201180977 | chr13:37880516-37880517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs56102112 | chr13:37880517-37880518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567454982 | chr13:37880519-37880520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs59123068 | chr13:37880531-37880532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10625988 | chr13:37880532-37880533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4943474 | chr13:37880543-37880544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4943475 | chr13:37880550-37880551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4943476 | chr13:37880557-37880558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4943477 | chr13:37880558-37880559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs60169011 | chr13:37880569-37880570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561184428 | chr13:37880571-37880572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371477045 | chr13:37880587-37880588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186817055 | chr13:37880589-37880590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11840304 | chr13:37880595-37880596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373252115 | chr13:37880596-37880597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201381916 | chr13:37880605-37880606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs369974825 | chr13:37880608-37880609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60491567 | chr13:37880609-37880610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs199603732 | chr13:37880610-37880611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543817123 | chr13:37880613-37880614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527619326 | chr13:37880614-37880615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563606758 | chr13:37880615-37880616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs57306644 | chr13:37880636-37880637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112698454 | chr13:37880640-37880641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199519408 | chr13:37880663-37880664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs5000233 | chr13:37880665-37880666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373674045 | chr13:37880666-37880667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61559189 | chr13:37880684-37880685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 17440070 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:37878600-37881200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr13:37879200-37880600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr13:37879400-37881200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
4 | chr13:37879600-37881800 | Enhancers | NHEK | skin |
5 | chr13:37879800-37881200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr13:37879800-37881200 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr13:37879800-37881800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr13:37880000-37880600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr13:37880000-37880800 | Weak transcription | HMEC | breast |
10 | chr13:37880000-37881200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr13:37880000-37881600 | Enhancers | NHDF-Ad | bronchial |
12 | chr13:37880200-37880600 | Weak transcription | Osteobl | bone |
13 | chr13:37880200-37880800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr13:37880200-37881800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr13:37880400-37880800 | Weak transcription | NH-A | brain |
16 | chr13:37880600-37881000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr13:37880600-37881000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr13:37880600-37881600 | Enhancers | Osteobl | bone |